Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1988 March; 81(3): 738–744.
PMCID: PMC442521

Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.


Lipid metabolism was studied in cultured skin fibroblasts from patients with the inherited disorder, Sjögren-Larsson syndrome (SLS). Intact SLS fibroblasts incubated in the presence of [1-14C]palmitate accumulated more radioactive hexadecanol than did normal cells, whereas incorporation of radioactivity into other cellular lipids was unaltered. The hexadecanol content of SLS fibroblasts was abnormally elevated. Hexadecanol accumulation was not due to increased fatty alcohol synthesis nor its deficient utilization for glycerol ether synthesis. The half-life of intracellular hexadecanol loaded into SLS fibroblasts was increased (70 min) compared with normal (15 min), and intact SLS fibroblasts showed impaired oxidation of [14C]-hexadecanol to fatty acid. Fatty alcohol:NAD+ oxidoreductase, the enzyme catalyzing this reaction, was deficient in SLS fibroblasts. Mean total activity in SLS fibroblasts (n = 5) was 13% of that in normal fibroblasts, and palmitoyl CoA-inhibitable activity was 1% of normal. Fibroblasts from two obligate SLS heterozygotes had enzyme activities intermediate between that in normal fibroblasts and individuals with SLS. These results suggest that the primary defect in SLS is deficiency of fatty alcohol:NAD+ oxidoreductase. SLS represents the first inherited disorder in man associated with an isolated abnormality in fatty alcohol metabolism.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • SJOGREN T, LARSSON T. Oligophrenia in combination with congenital ichthyosis and spastic disorders; a clinical and genetic study. Acta Psychiatr Neurol Scand Suppl. 1957;113:1–112. [PubMed]
  • Jagell S, Gustavson KH, Holmgren G. Sjögren-Larsson syndrome in Sweden. A clinical, genetic and epidemiological study. Clin Genet. 1981 Apr;19(4):233–256. [PubMed]
  • Webster D, France JT, Shapiro LJ, Weiss R. X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet. 1978 Jan 14;1(8055):70–72. [PubMed]
  • Angelini C, Philippart M, Borrone C, Bresolin N, Cantini M, Lucke S. Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation. Ann Neurol. 1980 Jan;7(1):5–10. [PubMed]
  • Williams ML, Koch TK, O'Donnell JJ, Frost PH, Epstein LB, Grizzard WS, Epstein CJ. Ichthyosis and neutral lipid storage disease. Am J Med Genet. 1985 Apr;20(4):711–726. [PubMed]
  • Austin J, Armstrong D, Shearer L. Metachromatic form of diffuse cerebral sclerosis. V. The nature and significance of low sulfatase activity: a controlled study of brain, liver and kidney in four patients with metachromatic leukodystrophy (MLD). Arch Neurol. 1965 Dec;13(6):593–614. [PubMed]
  • Williams CD, Avigan J. In vitro effects of serum proteins and lipids on lipid synthesis in human skin fibroblasts and leukocytes grown in culture. Biochim Biophys Acta. 1972 Mar 23;260(3):413–423. [PubMed]
  • Rizzo WB, Craft DA, Dammann AL, Phillips MW. Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle. J Biol Chem. 1987 Dec 25;262(36):17412–17419. [PubMed]
  • FOLCH J, LEES M, SLOANE STANLEY GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed]
  • Yao JK, Rastetter GM. Microanalysis of complex tissue lipids by high-performance thin-layer chromatography. Anal Biochem. 1985 Oct;150(1):111–116. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Horrocks LA. The alk-1-enyl group content of mammalian myelin phosphoglycerides by quantitative two-dimensional thin-layer chromatography. J Lipid Res. 1968 Jul;9(4):469–472. [PubMed]
  • Lee T. Characterization of fatty alcohol:NAD+ oxidoreductase from rat liver. J Biol Chem. 1979 Apr 25;254(8):2892–2896. [PubMed]
  • Krisans SK, Mortensen RM, Lazarow PB. Acyl-CoA synthetase in rat liver peroxisomes. Computer-assisted analysis of cell fractionation experiments. J Biol Chem. 1980 Oct 25;255(20):9599–9607. [PubMed]
  • Theile U. Sjögren-Larsson syndrome. Oligophrenia--ichthyosis--di-tetraplegia. Humangenetik. 1974 May 17;22(2):91–118. [PubMed]
  • Holmgren G, Jagell S, Seeman H, Steen G. Urinary amino acids and organic acids in the Sjögren-Larsson syndrome. Clin Genet. 1981 Jul;20(1):64–66. [PubMed]
  • Hooft C, Kriekemans J, van Acker K, Devos E, Traen S, Verdonk G. Sjögren-Larsson syndrome with exudative enteropathy. Influence of medium-chain triclycerides on the symptomatology. Helv Paediatr Acta. 1967 Oct;22(5):447–458. [PubMed]
  • Guilleminault CG, Harpey JP, Lafourcade J. Sjögren-Larsson syndrome. Report of two cases in twins. Neurology. 1973 Apr;23(4):367–373. [PubMed]
  • Sylvester PE. Pathological findings in Sjögren-Larsson syndrome. J Ment Defic Res. 1969 Dec;13(4):267–275. [PubMed]
  • Hernell O, Holmgren G, Jagell SF, Johnson SB, Holman RT. Suspected faulty essential fatty acid metabolism in Sjögren-Larsson syndrome. Pediatr Res. 1982 Jan;16(1):45–49. [PubMed]
  • Avigan J, Campbell BD, Yost DA, Hernell O, Holmgren G, Jagell SF. Sjögren-Larsson syndrome: delta 5-and delta 6-fatty acid desaturases in skin fibroblasts. Neurology. 1985 Mar;35(3):401–403. [PubMed]
  • Williams ML, Elias PM. Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis. J Clin Invest. 1981 Dec;68(6):1404–1410. [PMC free article] [PubMed]
  • Chanarin I, Patel A, Slavin G, Wills EJ, Andrews TM, Stewart G. Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J. 1975 Mar 8;1(5957):553–555. [PMC free article] [PubMed]
  • Miranda A, DiMauro S, Eastwood A, Hays A, Johnson WG, Olarte M, Whitlock R, Mayeux R, Rowland LP. Lipid storage myopathy, ichthyosis, and steatorrhea. Muscle Nerve. 1979 Jan-Feb;2(1):1–13. [PubMed]
  • Buxman MM, Goodkin PE, Fahrenbach WH, Dimond RL. Harlequin ichthyosis with epidermal lipid abnormality. Arch Dermatol. 1979 Feb;115(2):189–193. [PubMed]
  • Williams ML, Elias PM. Elevated n-alkanes in congenital ichthyosiform erythroderma. Phenotypic differentiation of two types of autosomal recessive ichthyosis. J Clin Invest. 1984 Jul;74(1):296–300. [PMC free article] [PubMed]
  • Riendeau D, Meighen E. Enzymatic reduction of fatty acids and acyl-CoAs to long chain aldehydes and alcohols. Experientia. 1985 Jun 15;41(6):707–713. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation